Literature DB >> 2996406

The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III.

D P Francis, H W Jaffe, P N Fultz, J P Getchell, J S McDougal, P M Feorino.   

Abstract

Over half of the persons infected with the lymphadenopathy-associated virus/human T-lymphotropic virus type III (LAV/HTLV-III), the retrovirus that causes the acquired immunodeficiency syndrome (AIDS), become persistently infected with the virus. These "carriers" serve as the major reservoir of infection for others. Virus from their vascular and lymphatic spaces infects others through direct blood or mucous membrane exposure. After months to years, a high proportion of those infected will develop clinical manifestations of infection. For infected homosexual men, approximately 25% have developed AIDS-related conditions, mainly lymphadenopathy, and approximately 10% have developed AIDS. Because of the large number of infected persons in the United States, increasing rates of disease can be expected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996406     DOI: 10.7326/0003-4819-103-5-719

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.

Authors:  F R Cleghorn; N Jack; J K Carr; J Edwards; B Mahabir; A Sill; C B McDanal; S M Connolly; D Goodman; R Q Bennetts; T R O'Brien; K J Weinhold; C Bartholomew; W A Blattner; M L Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Prognostic factors in acquired immunodeficiency syndrome.

Authors:  J D Wenger; C C Whalen; M M Lederman; T J Spech; J T Carey; J W Tomford; C S Landefeld
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

Review 3.  AIDS screening, confidentiality, and the duty to warn.

Authors:  L Gostin; W J Curran
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

4.  Practical management of common AIDS-related medical problems.

Authors:  H Hollander
Journal:  West J Med       Date:  1987-02

5.  Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.

Authors:  W Barcellini; P L Meroni; D Frasca; C Sguotti; M O Borghi; C Uberti-Foppa; P Buzzetti; A Lazzarin; G Doria; M Moroni
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 6.  Evidence for a Euro-American origin of human immunodeficiency virus (HIV).

Authors:  H P Katner; G A Pankey
Journal:  J Natl Med Assoc       Date:  1987-10       Impact factor: 1.798

7.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.

Authors:  P N Fultz; H M McClure; R B Swenson; C R McGrath; A Brodie; J P Getchell; F C Jensen; D C Anderson; J R Broderson; D P Francis
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.

Authors:  J V Giorgi; P G Nishanian; I Schmid; L E Hultin; H L Cheng; R Detels
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

9.  Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major.

Authors:  P E Manconi; C Dessí; G Sanna; F Argiolu; P Pellegrini-Bettoli; R Piro; O Masotti; A Cao
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

10.  Time of exposure and risk of HIV infection in homosexual partners of men with AIDS.

Authors:  D Osmond; P Bacchetti; R E Chaisson; T Kelly; R Stempel; J Carlson; A R Moss
Journal:  Am J Public Health       Date:  1988-08       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.